
    
      Study Type: Interventional Study Design: Randomized, single-dose, two-way crossover design
      under fasting conditions

      Official Title: A Relative Bioavailability Study of 800 mg Gabapentin Tablets Under Fasting
      Conditions

      Further study details as provided by Actavis Elizabeth LLC:

      Primary Outcome Measures:

      Rate and Extend of Absorption
    
  